OFIX ORTHOFIX MEDICAL

Ownership history in MARSHALL WACE, LLP  ·  19 quarters on record

This page tracks every 13F SEC filing in which MARSHALL WACE, LLP reported a position in ORTHOFIX MEDICAL (OFIX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.1% (2019 Q2)
Avg. % of fund
0.02%
First filed
2018 Q3
Last filed
2025 Q3
Quarters held
19
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 66,452 -94,971 -58.8% 0.00% $973K $14.64
2025 Q1 ADDED 161,423 +13,380 +9.0% 0.00% $2.6M $16.31
2024 Q4 REDUCED 148,043 -13,993 -8.6% 0.00% $2.6M $17.46
2024 Q3 REDUCED 162,036 -3,321 -2.0% 0.00% $2.5M $15.62
15 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    OFIX price (monthly, adj. close)
← Back to MARSHALL WACE, LLP Holdings